Pathstone Holdings
THC icon

Pathstone Holdings’s Tenet Healthcare THC Stock Holding History

Pathstone Holdings’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.23M Sell
17,292
-2,651
-13% -$487K 0.01% 856
2026
Q1 		$3.76M Sell
19,943
-87
-0.4% -$18.3K 0.02% 696
2025
Q4 		$3.98M Buy
20,030
+1,435
+8% +$290K 0.02% 660
2025
Q3 		$3.78M Buy
18,595
+2,485
+15% +$441K 0.01% 675
2025
Q2 		$2.84M Buy
16,110
+7,223
+81% +$1.09M 0.01% 801
2025
Q1 		$1.2M Buy
8,887
+253
+3% +$33.3K 0.01% 1286
2024
Q4 		$1.09M Sell
8,634
-339
-4% -$50.4K ﹤0.01% 1324
2024
Q3 		$1.49M Buy
8,973
+233
+3% +$35.2K 0.01% 1154
2024
Q2 		$1.16M Buy
8,740
+614
+8% +$73.9K 0.01% 1237
2024
Q1 		$854K Buy
8,126
+561
+7% +$50.4K ﹤0.01% 1375
2023
Q4 		$572K Buy
+7,565
New +$480K ﹤0.01% 1413

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Pathstone Holdings's THC Position: Q2 2026 in Review

Pathstone Holdings reduced its Tenet Healthcare (THC) stake by 13% in Q2 2026, selling an estimated $487K and leaving 17,292 shares worth $3.23M. The position accounts for 0.01% of the portfolio, ranked #856.

Pathstone Holdings first reported a position in THC in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.98M in Q4 2025. 678 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Pathstone Holdings held 17,292 shares of Tenet Healthcare worth $3.23M as of Q2 2026.
  • Pathstone Holdings sold 2,651 Tenet Healthcare shares in Q2 2026, an estimated $487K.
  • Tenet Healthcare made up 0.01% of Pathstone Holdings's portfolio in Q2 2026, its #856 holding.
  • Pathstone Holdings first reported a position in Tenet Healthcare in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Tenet Healthcare position peaked at $3.98M in Q4 2025.
  • 678 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.